RONALD ALLIGOOD: Open Payments
NPI 1407936800 · CHAPEL HILL, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,770 in 77 payments from 10 companies in 2025. Trend: 2023 $93 · 2024 $539 · 2025 $1,770
Food & beverage: $1,660Education: $109
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $386 |
| Alkermes, Inc. | 20 | $385 |
| Teva Pharmaceuticals USA, Inc. | 13 | $367 |
| ABBVIE INC. | 15 | $244 |
| Janssen Pharmaceuticals, Inc | 6 | $151 |
| Lundbeck LLC | 2 | $57 |
| Neurocrine BioSciences, Inc. | 2 | $57 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| Indivior Inc. | 1 | $43 |
| Luye Pharma (USA) Ltd. | 2 | $34 |
Products named: ARISTADA, VRAYLAR, AUSTEDO XR, REXULTI, ABILIFY MAINTENA, INVEGA SUSTENNA, LYBALVI, ABILIFY ASIMTUFII.
Industry payments across NC — which companies pay providers there.
